Page 16 - MDA MIDEC 2024 Programme Book

DAY 1 - CONFERENCE SPEAKER DAY 1 - CONFERENCE SPEAKER

Dr. Winnie Choi Wing Shan
■ Consultant (Dent)
■ Department of Dentistry and Maxillofacial Surgery
■ United Christian Hospital
■ Completed BDS, MDS and PhD at the Faculty of Dentistry, the
University of Hong Kong
■ Specialist in Oral & Maxillofacial Surgery in Hong Kong since 2010
■ Has been Chief examiner in specialty board exam in Hong Kong
■ Currently works as Consultant in the Department of Dentistry and
Maxillofacial Surgery at United Christian Hospital, Hong Kong
■ Practises wide scope of Maxillofacial Surgery, including Oral
oncology and microvascular reconstruction, orthognathic surgery
and obstructive sleep apnea, cleft and craniofacial syndromes, orofacial
pain

Speaker’s Lecture :
An Update on MRONJ Prevention, Detection and Management of
MRONJ in General Dental Practice

Learning objectives
■ To learn the risk factors of MRONJ
■ To learn about the clinical manifestations and staging of MRONJ
■ To learn about the management of MRONJ

Medication-related osteonecrosis of the jaw (MRONJ) is associated with
the use of antiresorptive agents like bisphosphonates and denosumab
for treating osteoporosis and some cancers. With the increasing number
of patients taking these antiresorptive agents, the incidence of MRONJ
has also increased. Risk factors of MRONJ include the amount of total
medication exposure, presence of dental diseases, operative dental
procedures, increased age, medical co-morbidity. Dental practitioners
play an important role in the prevention, detection and management of
MRONJ. Strategies for managing MRONJ patients will be discussed in this
lecture.

PAGE16 PAGE17